国产喹硫平治疗复发性精神分裂症的临床对照研究  

A comparative clinical study of quetiapine in the treatment of relapses schizophrenia

作　　者：刘文英[1] 高欢[1] 

机构地区：[1]广东省深圳市康宁医院,广东深圳518020

出　　处：《中国民康医学》2003年第12期725-726,共2页Medical Journal of Chinese People’s Health

摘　　要：目的:检验国产喹硫平治疗复发性精神分裂症的疗效和安全性。方法:对44例复发性精神分裂症患者给予国产喹硫平治疗,并与21例首发精神分裂症进行对照观察,疗程为16周。采用简明精神病评定量表(BPRS)评定疗效,副作用量表(TESS)评定不良反应。结果:国产喹硫平治疗复发性精神分裂症的疗效、依从性和副反应与首发精神分裂症相似,且有对血清泌乳素影响甚小的特点。结论:国产喹硫平是治疗复发性精神分裂症的安全、有效的新型抗精神病药物之一。Objective:To investigate the efficacy and safety of quetiapine for treatment of relapses schizophrenia. Methods:44 cases of relapses schizophrenia and 21 cases of first schizophrenia have taken quetiapine for sixteen weeks. The BRPS and TESS was adopted for evaluating therapeutic effect and side effect. Results: The total effective rates for relapses schizophrenia and first schizophrenia in quetiapine were similar. Conclusion: The domestic quetiapine is an effective and safe for the relapses schizophrenia.

关 键 词：喹硫平 治疗 复发性精神分裂症 不良反应 精神病 中国 

分 类 号：R749.3[医药卫生—神经病学与精神病学]